Human Genome Epidemiology Literature Finder
|
Records 1 - 7 (of 7 Records) |
| Query Trace: Urinary Bladder Neoplasms and IMPACT[original query] |
|---|
| A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003 Jan 12 (1): 68-70. Johne Andreas, Roots Ivar, Brockmöller Jürg |
| Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer genetics and cytogenetics 2010 Dec 203 (2): 263-8. Pandith Arshad A, Shah Zafar A, Khan Nighat P, Rasool Roohi, Afroze Dil, Yousuf Adfar, Wani Saleem, Siddiqi Musht |
| Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA and cell biology 2011 Jun 30 (6): 401-6. Mittal Rama Devi, Gangwar Ruchika, George Ginu P, Mittal Tulika, Kapoor Rake |
| hTERT cancer risk genotypes are associated with telomere length. Genetic epidemiology 2012 May 36 (4): 368-72. Melin Beatrice S, Nordfjäll Katarina, Andersson Ulrika, Roos Gör |
| Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Archives of toxicology 2013 Dec 87 (12): 2129-39. Selinski Silvia, Blaszkewicz Meinolf, Ickstadt Katja, Hengstler Jan G, Golka Kla |
| Influence of single nucleotide polymorphisms among cigarette smoking and non-smoking patients with coronary artery disease, urinary bladder cancer and lung cancer. PloS one 2021 16 (1): e0243084. Laytragoon Lewin Nongnit, Karlsson Jan-Erik, Robinsson David, Fagerberg Matida, Kentsson Magnus, Sayardoust Shariel, Nilsson Mats, Shamoun Levar, Andersson Bengt-Åke, Löfgren Sture, Rutqvist Lars Erik, Lewin Fred |
| ABO Blood Type and Urinary Bladder Cancer: Phenotype, Genotype, Allelic Association with a Clinical or Histological Stage and Recurrence Rate. Global medical genetics 2024 7 11 (3): 233-240. Ivan Milas, Ċ½eljko Kaštelan, Jószef Petrik, Jasna Bingulac-Popovi?, Bojan ?iki?, Andrej Šribar, Irena Juk |
- Page last reviewed:Feb 1, 2024
- Content source:

